​
​

Mangoceuticals Stock (NASDAQ:MGRX)

RevenueOwnershipFinancialsChart
Mangoceuticals by TradingView

Previous Close

$2.31

52W Range

$2.10 - $16.80

50D Avg

$3.06

200D Avg

$4.13

Market Cap

$4.65M

Avg Vol (3M)

$360.35K

Beta

-

Div Yield

-

MGRX Company Profile

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Mar 21, 2023

Website

MGRX Performance

MGRX Financial Summary

Dec 23Dec 22Dec 21
Revenue-$8.94K-
Operating Income-$-1.99M$-17.52K
Net Income-$-2.00M$-17.70K
EBITDA-$-1.99M$-17.52K
Basic EPS-$-0.12-
Diluted EPS-$-0.12-

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
SNCEScience 37 Holdings, Inc.
ETAOETAO International Co., Ltd.
BFRGBullfrog AI Holdings, Inc. Common Stock
HCTIHealthcare Triangle, Inc.
AKLIAkili, Inc.
UTRSMinerva Surgical, Inc.
AUGXAugmedix, Inc.
EUDAEUDA Health Holdings Limited